Poly-L-lactic acid (PLLA) is formulated into microspheres rather than irregular particles to minimize tissue irritation, reduce the incidence of adverse reactions such as granulomas and nodules, and enhance safety. Key factors determining the product's safety and its efficacy in stimulating collagen regeneration include the molecular weight and particle size of the microspheres, as well as their uniform distribution within the suspension.
Mainstream manufacturing processes include the emulsion-solvent evaporation method, spray drying, and microfluidic technology. As a cornerstone of industrial production, the emulsion-solvent evaporation method allows for flexible particle size control by adjusting shear rates; it offers high encapsulation efficiency for hydrophobic agents and is well-suited for the large-scale production of aesthetic filler microspheres. Spray drying employs a one-step sphere-formation technique that eliminates solvent residues-thereby avoiding the toxicity risks associated with organic solvents-making it particularly suitable for heat-sensitive drug carriers such as proteins and peptides. Microfluidic technology utilizes the laminar flow focusing effect to achieve precise shearing within microchannels, yielding microspheres with highly uniform size distribution, which is ideal for high-value, nanoscale formulations.
The industry is currently exploring hybrid processes-such as the combination of emulsification and microfluidics-to achieve even more precise control over particle size. Future technological breakthroughs will focus on organic solvent replacement strategies, the synergistic control of particle size and porosity, and the integration of continuous production lines.

